Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision stamp was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update updates the page tracking without changing the study details presented.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status updated to no longer accept participants, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). There is also a formatting update to the Intervention/Treatment label and the revision note changed from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check27 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This indicates a minor internal update to the page version without changing the displayed study details.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision tag, Revision: v3.5.4, has been added to the page. This replaces the previous Revision: v3.5.3, indicating an updated version of the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the displayed study information.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.